Boston to axe over 1,000 jobs as Q3 hints at turnaround
This article was originally published in Clinica
Executive Summary
Boston Scientific has announced another raft of job cuts on the eve of its third-quarter results, adding to some already hefty rounds of the axe in recent years. This time, the company plans to eliminate 1,100-1,500 of its 24,000-strong workforce as part of a 2014 restructuring plan aimed at saving $150-200m per year, according to a filing with the US Securities and Exchange Commission (SEC).